Search bioRxiv⌕ Search

Biology subjects

Alizadeh, J.

Publications and source records attributed to Alizadeh, J..

4 recordsLinked to original sources

Autophagy Cholesterol Axis Remodeling Supports Malignant Progression and Chemoresistance in Glioma

Glioma progression and resistance to temozolomide (TMZ) remain major clinical challenges. Here, we investigated whether dysregulated autophagy and cholesterol metabolism are coordinately remodeled during glioma progression and TMZ resistance. Tissue microarray analysis of astrocytoma and glioblastoma specimens revealed progressive autophagosome accumulation, reflected by increased LC3{beta} puncta, coupled with impaired autophagic flux compared with adjacent normal brain tissue. These alterations intensified with tumor grade and were associated with upregulation of farnesyl diphosphate synthase (FDPS), linking malignant progression to cholesterol pathway remodeling. TMZ-resistant (R) glioblastoma cells exhibited epithelial-to-mesenchymal transition, mitotic quiescence, and mitochondrial remodeling consistent with a therapy-tolerant phenotype. Bioenergetic profiling demonstrated reduced respiratory reserve, diminished ATP-linked respiration, and elevated proton leak, indicating constrained metabolic flexibility. In parallel, impaired autophagy flux was associated with suppression of de novo cholesterol synthesis and transcriptional downregulation of SREBP-2 and LDL-R. Comprehensive lipidomic profiling revealed marked cholesterol metabolic reprogramming in R cells, characterized by accumulation of specific cholesteryl esters, including CE 22:5, CE 22:6, CE 22:4, and CE 20:4, despite reduced cholesterol biosynthesis. Pharmacologic inhibition of the mevalonate pathway with simvastatin significantly altered cholesteryl ester profiles but failed to restore autophagy flux or sensitize R cells to TMZ-induced apoptosis, even under combined TMZ-simvastatin treatment. Lay AbstractAs gliomas progress from astrocytoma to glioblastoma, autophagy becomes dysregulated and cholesterol metabolism is rewired. This coordinated remodeling supports tumor survival, metabolic plasticity, and resistance to temozolomide therapy. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=133 SRC="FIGDIR/small/697885v2_ufig1.gif" ALT="Figure 1000"> View larger version (79K): org.highwire.dtl.DTLVardef@1183dd2org.highwire.dtl.DTLVardef@82e20dorg.highwire.dtl.DTLVardef@c6c8dforg.highwire.dtl.DTLVardef@adb427_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsAutophagy flux blockade intensifies during progression from astrocytoma to glioblastoma Dysregulated autophagy is coupled to altered cholesterol metabolism in malignant gliomas TMZ-resistant glioblastoma cells undergo epithelial-to-mesenchymal transition and mitotic quiescence Resistant cells exhibit constrained bioenergetic capacity and mitochondrial remodeling Impaired autophagy suppresses de novo cholesterol synthesis and lipid recycling Lipidomics reveals accumulation of long-chain cholesteryl esters in TMZ-resistant cells Statin-based cholesterol inhibition fails to resensitize glioblastoma cells to temozolomide

cancer biology↗

A Lipidomics Approach to Determine the Role of Lipids and its Crosstalk with Autophagy in Lung Cancer Metastasis

Summary/AbstractNon-small cell lung cancer (NSCLC) is among the most malignant tumors with high propensity for metastasis and is the leading cause of cancer-related death globally. Most patients present with regional and distant metastasis, associated with poor prognosis. Lipids may play an essential role in either activating or inhibiting detachment-induced apoptosis (anoikis), where the latter is a crucial mechanism to prevent metastasis, and it may have a cross-talk with autophagy. Autophagy has been shown to be induced in various human cancer metastasis, modulating tumor cell motility and invasion, cancer cell differentiation, resistance to anoikis, and epithelial to mesenchymal transition. Hence, it may play a crucial role in the transition of benign to malignant phenotypes, the core of metastasis initiation. Here, we provide a method we have established in our laboratory for detecting of lipids in attached and detached non-small lung cancer cells and show how to analyze lipidomics data to find its correlation with autophagy-related pathways. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=95 SRC="FIGDIR/small/573842v2_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@1127909org.highwire.dtl.DTLVardef@1c86359org.highwire.dtl.DTLVardef@f29722org.highwire.dtl.DTLVardef@a05a7d_HPS_FORMAT_FIGEXP M_FIG C_FIG Workflow of A549 attached and detached cell culture. Cells are collected, lipids are extracted and subjected to LC/MS processing. Next, lipidomics resulting data is analyzed through various steps involving utilization of Metaboanlyst, HDMB, Swiss Target Prediction, and String.

cancer biology↗

A multi-omics analysis of glioma chemoresistance using a hybrid microphysiological model of glioblastoma

Chemoresistance is a major clinical challenge in the management of glioblastoma (GBM) Temozolomide (TMZ) is the chemotherapeutic drug of choice for GBM; however, the therapeutic effect of TMZ is limited due to the development of resistance. Recapitulating GBM chemoresistance in a controlled environment is thus essential in understanding the mechanism of chemoresistance. Herein, we present a hybrid microphysiological model of chemoresistant GBM-on-a-chip (HGoC) by directly co-culturing TMZ-resistant GBM spheroids with healthy neurons to mimic the microenvironment of both the tumor and the surrounding healthy tissue. We characterized the model with proteomics, lipidomics, and secretome assays. The results showed that our artificial model recapitulated the molecular signatures of recurrent GBM in humans. Both showed alterations in vesicular transport and cholesterol pathways, mitotic quiescence, and a switch in metabolism to oxidative phosphorylation associated with a transition from mesenchymal to amoeboid. This is the first report to unravel the interplay of all these molecular changes as a mechanism of chemoresistance in glioblastoma. Moreover, we have shown that the acquisition of resistance increases invasiveness and the presence of neurons decreases this property.

bioengineering↗

Multivariate pattern analysis reveals location specific aftereffects of 10Hz motor cortex transcranial alternating current stimulation

BackgroundTranscranial alternating current stimulation (tACS) may induce frequency-specific aftereffects on brain oscillations in the stimulated location, which could serve as evidence for region-specific neuroplasticity. Aftereffects of tACS on the motor system remain unknown. ObjectiveTo find evidence for aftereffects in short EEG segments following tACS to two critical nodes of the motor network, namely, left motor cortex (lMC) and right cerebellum (rCB). We hypothesized that aftereffects of lMC will be stronger in and around lMC compared to both active stimulation of rCB, as well as inactive ("sham") control conditions. MethodsTo this end, we employed multivariate pattern analysis (MVPA), and trained a classifier to distinguish between EEG signals following each of the three stimulation protocols. This method accounts for the multitude facets of the EEG signal and thus is more sensitive to subtle modulation of the EEG signal. ResultsEEG signals in both theta ({theta}, 4-8Hz) and alpha (, 8-13Hz) were better classified to lMC-tACS compared to rCB-tACS/sham, in and around lMC-tACS stimulation locations (electrodes FC3 and CP3). This effect was associated with a decrease in power following tACS. Source reconstruction revealed significant differences in premotor cortex but not in primary motor cortex as the computational model suggested. Correlation between classification accuracies in {theta} and in lMC-tACS was stronger compared to rCB-tACS/sham, suggesting cross-frequency effects of tACS. Nonetheless, {theta}/ phase-coupling did not differ between stimulation protocols. ConclusionsSuccessful classification of EEG signals to left motor cortex using MVPA revealed focal tACS aftereffects on the motor cortex, indicative of region-specific neuroplasticity.

neuroscience↗